speb/financial-data huggingface dataset:
CVCO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 42461000.00
CVCO cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 190551000.00
CVCO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 42461000.00
CVCO income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 190551000.00
CVCO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 42461000.00
CVCO income_statement (annual, 2026-03-31) — Net Interest Income: 15796000.00
CVCO income_statement (quarterly, 2026-03-31) — Net Interest Income: 3098000.00
CVCO cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -14450000.00
CVCO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -13246000.00
CVCO cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -295000.00
CVCO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -111000.00
CVCO cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -295000.00
CVCO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -111000.00
CVCO income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 15796000.00
CVCO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3098000.00
CVCO cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -4836000.00
CVCO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 113000.00
CVCO balance_sheet (annual, 2026-03-31) — Net PPE: 312468000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Net PPE: 312468000.00
CVCO cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -35203000.00
CVCO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -8001000.00
CVCO balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 866274000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 866274000.00
CVCO balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 0.00
CVCO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 0.00
CVCO balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 14716000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 14716000.00
CVCO balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
CVCO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
CVCO balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 14716000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 14716000.00
CVCO balance_sheet (annual, 2026-03-31) — Non Current Note Receivables: 78294000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 78294000.00
CVCO income_statement (annual, 2026-03-31) — Normalized EBITDA: 268284000.00
CVCO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 61065000.00
CVCO income_statement (annual, 2026-03-31) — Normalized Income: 190551000.00
CVCO income_statement (quarterly, 2026-03-31) — Normalized Income: 42461000.00
CVCO cash_flow (annual, 2026-03-31) — Operating Cash Flow: 267491000.00
CVCO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 67372000.00
CVCO cash_flow (annual, 2026-03-31) — Operating Gains Losses: -4755000.00
CVCO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1040000.00
CVCO income_statement (annual, 2026-03-31) — Operating Income: 228569000.00
CVCO income_statement (quarterly, 2026-03-31) — Operating Income: 51473000.00
CVCO income_statement (annual, 2026-03-31) — Operating Revenue: 2244505000.00
CVCO income_statement (quarterly, 2026-03-31) — Operating Revenue: 550127000.00
CVCO balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 7738700.00
CVCO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 7738700.00
CVCO balance_sheet (annual, 2026-03-31) — Other Current Assets: 71630000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 71630000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 64321000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 64321000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 30000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 30000.00
CVCO income_statement (annual, 2026-03-31) — Other Income Expense: 335000.00
CVCO income_statement (quarterly, 2026-03-31) — Other Income Expense: -20000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 28067000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 28067000.00
CVCO cash_flow (annual, 2026-03-31) — Other Non Cash Items: 227922000.00
CVCO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 74947000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 585000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 585000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 7096000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 7096000.00
CVCO income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 335000.00
CVCO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -20000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Properties: 33578000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Properties: 33578000.00
CVCO balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 16233000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 16233000.00
CVCO balance_sheet (annual, 2026-03-31) — Payables: 44168000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Payables: 44168000.00
CVCO balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 207171000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 207171000.00
CVCO balance_sheet (annual, 2026-03-31) — Preferred Stock: 0.00
CVCO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CVCO income_statement (annual, 2026-03-31) — Pretax Income: 244700000.00
CVCO income_statement (quarterly, 2026-03-31) — Pretax Income: 54551000.00
CVCO cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 2232000.00
CVCO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 348000.00
CVCO balance_sheet (annual, 2026-03-31) — Properties: 0.00
CVCO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CVCO cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -589000.00
CVCO cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -413000.00
CVCO cash_flow (annual, 2026-03-31) — Purchase Of Business: -172784000.00
CVCO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -1338000.00
CVCO cash_flow (annual, 2026-03-31) — Purchase Of Investment: -34519000.00
CVCO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -15567000.00
CVCO cash_flow (annual, 2026-03-31) — Purchase Of PPE: -35406000.00
CVCO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -8046000.00
CVCO balance_sheet (annual, 2026-03-31) — Raw Materials: 87180000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 87180000.00
CVCO balance_sheet (annual, 2026-03-31) — Receivables: 184172000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Receivables: 184172000.00
CVCO income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1717618000.00
CVCO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 423074000.00
CVCO income_statement (annual, 2026-03-31) — Reconciled Depreciation: 23043000.00
CVCO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6380000.00
CVCO cash_flow (annual, 2026-03-31) — Repayment Of Debt: -295000.00
CVCO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -111000.00
CVCO cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -159888000.00
CVCO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -29997000.00
CVCO balance_sheet (annual, 2026-03-31) — Restricted Cash: 20306000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 20306000.00
CVCO balance_sheet (annual, 2026-03-31) — Retained Earnings: 1388714000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1388714000.00
CVCO cash_flow (annual, 2026-03-31) — Sale Of Investment: 20069000.00
CVCO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 2321000.00
CVCO cash_flow (annual, 2026-03-31) — Sale Of PPE: 203000.00
CVCO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 45000.00
CVCO income_statement (annual, 2026-03-31) — Selling General And Administration: 298318000.00
CVCO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 75580000.00
CVCO balance_sheet (annual, 2026-03-31) — Share Issued: 9474288.00
CVCO balance_sheet (quarterly, 2026-03-31) — Share Issued: 9474288.00
CVCO cash_flow (annual, 2026-03-31) — Stock Based Compensation: 12783000.00
CVCO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2518000.00
CVCO balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1103182000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1103182000.00
CVCO balance_sheet (annual, 2026-03-31) — Tangible Book Value: 866274000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 866274000.00
CVCO income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CVCO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CVCO income_statement (annual, 2026-03-31) — Tax Provision: 54149000.00
CVCO income_statement (quarterly, 2026-03-31) — Tax Provision: 12090000.00
CVCO income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.22
CVCO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
CVCO balance_sheet (annual, 2026-03-31) — Total Assets: 1491139000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1491139000.00
CVCO balance_sheet (annual, 2026-03-31) — Total Capitalization: 1103182000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1103182000.00
CVCO balance_sheet (annual, 2026-03-31) — Total Debt: 30747000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Debt: 30747000.00
CVCO balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1103182000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1103182000.00
CVCO income_statement (annual, 2026-03-31) — Total Expenses: 2015936000.00
CVCO income_statement (quarterly, 2026-03-31) — Total Expenses: 498654000.00
CVCO balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 387957000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 387957000.00
CVCO balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 666406000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 666406000.00
CVCO balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 52559000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 52559000.00
CVCO income_statement (annual, 2026-03-31) — Total Operating Income As Reported: 228569000.00
CVCO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 51473000.00
CVCO balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 1735588.00
CVCO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 1735588.00
CVCO balance_sheet (annual, 2026-03-31) — Treasury Stock: 585865000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 585865000.00
CVCO balance_sheet (annual, 2026-03-31) — Work In Process: 34968000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Work In Process: 34968000.00
CVCO balance_sheet (annual, 2026-03-31) — Working Capital: 489335000.00
CVCO balance_sheet (quarterly, 2026-03-31) — Working Capital: 489335000.00
CVE cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 1549000000.00
CVE balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 1304000000.00
CVE cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -1227000000.00
CVE cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -176000000.00
CVE balance_sheet (annual, 2021-12-31) — Current Debt: 79000000.00
CVE cash_flow (annual, 2021-12-31) — Depreciation: 4322000000.00
CVE cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 4322000000.00
CVE balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 371000000.00
CVE cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 209000000.00
CVE cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 811000000.00
CVE balance_sheet (annual, 2021-12-31) — Investment Properties: 500000000.00
CVE balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 311000000.00
CVE cash_flow (annual, 2021-12-31) — Issuance Of Debt: 1557000000.00
CVE cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 1557000000.00
CVE balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 1841000000.00
CVE income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
CVE cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 8000000.00
CVE cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
CVE balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 41000000.00
CVE balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 538000000.00
CVE balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 78000000.00
CVE cash_flow (annual, 2021-12-31) — Preferred Stock Dividend Paid: -34000000.00
CVE cash_flow (annual, 2021-12-31) — Purchase Of PPE: 0.00
CVE income_statement (annual, 2022-12-31) — +Operating Expense: 6782000000.00
CVE income_statement (annual, 2022-12-31) — +Total Revenue: 71765000000.00
CVE balance_sheet (annual, 2022-12-31) — Accounts Payable: 2331000000.00
CVE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2962000000.00
CVE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -22082000000.00
CVE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2691000000.00
CVE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 315000000.00
CVE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
CVE income_statement (annual, 2022-12-31) — Basic Average Shares: 1951300000.00
CVE income_statement (annual, 2022-12-31) — Basic EPS: 3.29
CVE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2873000000.00
CVE cash_flow (annual, 2022-12-31) — Capital Expenditure: -3758000000.00
CVE cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -3708000000.00
CVE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2836000000.00
CVE balance_sheet (annual, 2022-12-31) — Capital Stock: 16839000000.00
CVE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4524000000.00
CVE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4524000000.00
CVE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -927000000.00
CVE balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1329000000.00
CVE balance_sheet (annual, 2022-12-31) — Cash Financial: 3195000000.00
CVE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -7676000000.00
CVE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2314000000.00
CVE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 11403000000.00
CVE cash_flow (annual, 2022-12-31) — Change In Working Capital: 575000000.00
CVE cash_flow (annual, 2022-12-31) — Changes In Cash: 1413000000.00
CVE balance_sheet (annual, 2022-12-31) — Common Stock: 16320000000.00
CVE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -901000000.00
CVE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 27057000000.00
CVE cash_flow (annual, 2022-12-31) — Common Stock Payments: -2530000000.00
CVE income_statement (annual, 2022-12-31) — Cost Of Revenue: 54631000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 3501000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Assets: 12430000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 308000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Debt: 115000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 423000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Liabilities: 8021000000.00
CVE balance_sheet (annual, 2022-12-31) — Current Provisions: 25000000.00
CVE cash_flow (annual, 2022-12-31) — Deferred Income Tax: 642000000.00
CVE cash_flow (annual, 2022-12-31) — Deferred Tax: 642000000.00
CVE cash_flow (annual, 2022-12-31) — Depreciation: 4364000000.00
CVE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 4679000000.00
CVE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 4364000000.00
CVE income_statement (annual, 2022-12-31) — Diluted Average Shares: 2006100000.00
CVE income_statement (annual, 2022-12-31) — Diluted EPS: 3.20
CVE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6415000000.00
CVE cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 65000000.00
CVE balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 51000000.00
CVE balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 0.00
CVE income_statement (annual, 2022-12-31) — EBIT: 9543000000.00
CVE income_statement (annual, 2022-12-31) — EBITDA: 14222000000.00
CVE income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 15000000.00
CVE cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -15000000.00
CVE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 238000000.00
CVE balance_sheet (annual, 2022-12-31) — Employee Benefits: 446000000.00
CVE cash_flow (annual, 2022-12-31) — End Cash Position: 4524000000.00
CVE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -7676000000.00
CVE balance_sheet (annual, 2022-12-31) — Finished Goods: 4009000000.00
CVE cash_flow (annual, 2022-12-31) — Free Cash Flow: 7645000000.00
CVE cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -126000000.00
CVE income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 818000000.00
CVE income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1979000000.00
CVE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1470000000.00
CVE income_statement (annual, 2022-12-31) — General And Administrative Expense: 865000000.00
CVE balance_sheet (annual, 2022-12-31) — Goodwill: 2923000000.00
CVE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2942000000.00
CVE balance_sheet (annual, 2022-12-31) — Gross PPE: 61111000000.00
CVE income_statement (annual, 2022-12-31) — Gross Profit: 17134000000.00
CVE cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 723000000.00
CVE balance_sheet (annual, 2022-12-31) — Income Tax Payable: 1211000000.00
CVE income_statement (annual, 2022-12-31) — Interest Expense: 812000000.00
CVE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 812000000.00
CVE income_statement (annual, 2022-12-31) — Interest Income: 110000000.00
CVE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 110000000.00
CVE cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 647000000.00
CVE balance_sheet (annual, 2022-12-31) — Interest Payable: 80000000.00
CVE balance_sheet (annual, 2022-12-31) — Inventory: 4312000000.00
CVE balance_sheet (annual, 2022-12-31) — Invested Capital: 35863000000.00
CVE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2314000000.00
CVE balance_sheet (annual, 2022-12-31) — Investments And Advances: 482000000.00
CVE balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 55000000.00
CVE balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 365000000.00
CVE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CVE balance_sheet (annual, 2022-12-31) — Leases: 599000000.00
CVE balance_sheet (annual, 2022-12-31) — Line Of Credit: 115000000.00
CVE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2528000000.00
CVE balance_sheet (annual, 2022-12-31) — Long Term Debt: 8691000000.00
CVE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 11219000000.00
CVE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CVE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4451000000.00
CVE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 420000000.00
CVE balance_sheet (annual, 2022-12-31) — Long Term Provisions: 3889000000.00
CVE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1840000000.00
CVE balance_sheet (annual, 2022-12-31) — Minority Interest: 13000000.00
CVE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 1117000000.00
CVE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -2530000000.00
CVE balance_sheet (annual, 2022-12-31) — Net Debt: 4282000000.00
CVE cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 511000000.00
CVE income_statement (annual, 2022-12-31) — Net Income: 6450000000.00
CVE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6415000000.00
CVE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6450000000.00
CVE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6450000000.00
CVE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6450000000.00
CVE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6450000000.00
CVE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6450000000.00
CVE income_statement (annual, 2022-12-31) — Net Interest Income: -739000000.00
CVE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -211000000.00
CVE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -4417000000.00
CVE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -4451000000.00
CVE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -739000000.00
CVE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2000000.00
CVE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 538000000.00
CVE balance_sheet (annual, 2022-12-31) — Net PPE: 39029000000.00
CVE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -50000000.00
CVE cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 34000000.00
CVE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 24634000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 145000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 546000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4328000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 45000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 546000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4283000000.00
CVE balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 201000000.00
CVE income_statement (annual, 2022-12-31) — Normalized EBITDA: 15651000000.00
CVE income_statement (annual, 2022-12-31) — Normalized Income: 7506031000.00
CVE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 11403000000.00
CVE cash_flow (annual, 2022-12-31) — Operating Gains Losses: 101000000.00
CVE income_statement (annual, 2022-12-31) — Operating Income: 10352000000.00
CVE income_statement (annual, 2022-12-31) — Operating Revenue: 71765000000.00
CVE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1909190000.00
CVE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 302000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1470000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Equity Interest: 184000000.00
CVE income_statement (annual, 2022-12-31) — Other Gand A: 297000000.00
CVE income_statement (annual, 2022-12-31) — Other Income Expense: -882000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 19000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Investments: 62000000.00
CVE cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1109000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 295000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 377000000.00
CVE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 532000000.00
CVE income_statement (annual, 2022-12-31) — Other Operating Expenses: 5917000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Payable: 66000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Properties: 3739000000.00
CVE balance_sheet (annual, 2022-12-31) — Other Receivables: 58000000.00
CVE balance_sheet (annual, 2022-12-31) — Payables: 3608000000.00
CVE balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 7109000000.00
CVE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 162000000.00
CVE balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 36000000.00
CVE balance_sheet (annual, 2022-12-31) — Preferred Stock: 519000000.00
CVE cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -26000000.00
CVE income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 35000000.00
CVE balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 519000000.00
CVE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 402000000.00
CVE income_statement (annual, 2022-12-31) — Pretax Income: 8731000000.00
CVE cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 200000000.00
CVE cash_flow (annual, 2022-12-31) — Purchase Of Business: -397000000.00
CVE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -50000000.00
CVE balance_sheet (annual, 2022-12-31) — Raw Materials: 303000000.00
CVE balance_sheet (annual, 2022-12-31) — Receivables: 3192000000.00
CVE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 54631000000.00
CVE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 4679000000.00
CVE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4451000000.00
CVE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -2530000000.00
CVE income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 268000000.00
CVE balance_sheet (annual, 2022-12-31) — Retained Earnings: 6392000000.00
CVE income_statement (annual, 2022-12-31) — Salaries And Wages: 568000000.00
CVE cash_flow (annual, 2022-12-31) — Sale Of Business: 1514000000.00
CVE income_statement (annual, 2022-12-31) — Selling General And Administration: 865000000.00
CVE balance_sheet (annual, 2022-12-31) — Share Issued: 1909190000.00
CVE income_statement (annual, 2022-12-31) — Special Income Charges: 550000000.00
CVE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 27576000000.00
CVE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 24115000000.00
CVE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -372969000.00
CVE income_statement (annual, 2022-12-31) — Tax Provision: 2281000000.00
CVE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CVE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 121000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Assets: 55869000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Capitalization: 36267000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Debt: 11642000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 27589000000.00
CVE income_statement (annual, 2022-12-31) — Total Expenses: 61413000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 28280000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 43439000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 20259000000.00
CVE income_statement (annual, 2022-12-31) — Total Other Finance Cost: 37000000.00
CVE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1211000000.00
CVE income_statement (annual, 2022-12-31) — Total Unusual Items: -1429000000.00
CVE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1429000000.00
CVE balance_sheet (annual, 2022-12-31) — Working Capital: 4409000000.00
CVE income_statement (annual, 2023-12-31) — +Operating Expense: 7082000000.00
CVE income_statement (annual, 2023-12-31) — +Total Revenue: 55474000000.00
CVE balance_sheet (annual, 2023-12-31) — Accounts Payable: 1075000000.00
CVE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2722000000.00
CVE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -26228000000.00
CVE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2002000000.00
CVE cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 20000000.00
CVE income_statement (annual, 2023-12-31) — Basic Average Shares: 1895487000.00
CVE income_statement (annual, 2023-12-31) — Basic EPS: 2.15
CVE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4524000000.00
CVE cash_flow (annual, 2023-12-31) — Capital Expenditure: -4298000000.00
CVE cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -4298000000.00
CVE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2658000000.00
CVE balance_sheet (annual, 2023-12-31) — Capital Stock: 16550000000.00
CVE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2227000000.00
CVE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2227000000.00
CVE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1026000000.00
CVE balance_sheet (annual, 2023-12-31) — Cash Equivalents: 118000000.00
CVE balance_sheet (annual, 2023-12-31) — Cash Financial: 2109000000.00
CVE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -4313000000.00
CVE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5295000000.00
CVE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 7388000000.00
CVE cash_flow (annual, 2023-12-31) — Change In Working Capital: -1193000000.00
CVE cash_flow (annual, 2023-12-31) — Changes In Cash: -2220000000.00
CVE balance_sheet (annual, 2023-12-31) — Common Stock: 16031000000.00
CVE cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -990000000.00
CVE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 28179000000.00
CVE cash_flow (annual, 2023-12-31) — Common Stock Payments: -1061000000.00
CVE income_statement (annual, 2023-12-31) — Cost Of Revenue: 42770000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 4028000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Assets: 9708000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 299000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Debt: 179000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 478000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Liabilities: 6210000000.00
CVE balance_sheet (annual, 2023-12-31) — Current Provisions: 18000000.00
CVE cash_flow (annual, 2023-12-31) — Deferred Income Tax: -250000000.00
CVE cash_flow (annual, 2023-12-31) — Deferred Tax: -250000000.00
CVE cash_flow (annual, 2023-12-31) — Depreciation: 4624000000.00
CVE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4644000000.00
CVE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4624000000.00
CVE income_statement (annual, 2023-12-31) — Diluted Average Shares: 1925440000.00
CVE income_statement (annual, 2023-12-31) — Diluted EPS: 2.12
CVE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 4073000000.00
CVE cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 149000000.00
CVE balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 49000000.00
CVE income_statement (annual, 2023-12-31) — EBIT: 5763000000.00
CVE income_statement (annual, 2023-12-31) — EBITDA: 10407000000.00
CVE income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 51000000.00
CVE cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -51000000.00
CVE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -77000000.00
CVE balance_sheet (annual, 2023-12-31) — Employee Benefits: 376000000.00
CVE cash_flow (annual, 2023-12-31) — End Cash Position: 2227000000.00
CVE cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4313000000.00
CVE balance_sheet (annual, 2023-12-31) — Finished Goods: 3604000000.00
CVE cash_flow (annual, 2023-12-31) — Free Cash Flow: 3090000000.00
CVE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 52000000.00
CVE income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -20000000.00
CVE income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 6000000.00
CVE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1208000000.00
CVE income_statement (annual, 2023-12-31) — General And Administrative Expense: 688000000.00
CVE balance_sheet (annual, 2023-12-31) — Goodwill: 2923000000.00
CVE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2923000000.00
CVE balance_sheet (annual, 2023-12-31) — Gross PPE: 65896000000.00
CVE income_statement (annual, 2023-12-31) — Gross Profit: 12704000000.00
CVE cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2595000000.00
CVE balance_sheet (annual, 2023-12-31) — Income Tax Payable: 88000000.00
CVE income_statement (annual, 2023-12-31) — Interest Expense: 723000000.00
CVE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 723000000.00
CVE income_statement (annual, 2023-12-31) — Interest Income: 217000000.00
CVE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 217000000.00
CVE cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 402000000.00
CVE balance_sheet (annual, 2023-12-31) — Interest Payable: 69000000.00
CVE balance_sheet (annual, 2023-12-31) — Inventory: 4030000000.00
CVE balance_sheet (annual, 2023-12-31) — Invested Capital: 35466000000.00
CVE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5295000000.00
CVE balance_sheet (annual, 2023-12-31) — Investments And Advances: 558000000.00
CVE balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 131000000.00
CVE balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 366000000.00
CVE balance_sheet (annual, 2023-12-31) — Leases: 588000000.00
CVE balance_sheet (annual, 2023-12-31) — Line Of Credit: 179000000.00
CVE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2359000000.00
CVE balance_sheet (annual, 2023-12-31) — Long Term Debt: 7108000000.00
CVE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9467000000.00
CVE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1634000000.00
CVE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 497000000.00
CVE balance_sheet (annual, 2023-12-31) — Long Term Provisions: 4408000000.00
CVE balance_sheet (annual, 2023-12-31) — Minority Interest: 14000000.00
CVE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -503000000.00
CVE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1061000000.00
CVE balance_sheet (annual, 2023-12-31) — Net Debt: 5060000000.00
CVE cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -112000000.00
CVE income_statement (annual, 2023-12-31) — Net Income: 4109000000.00
CVE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 4073000000.00
CVE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 4109000000.00
CVE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4109000000.00
CVE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 4109000000.00
CVE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4109000000.00
CVE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4109000000.00
CVE income_statement (annual, 2023-12-31) — Net Interest Income: -538000000.00
CVE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -125000000.00
CVE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1576000000.00
CVE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -1634000000.00
CVE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -538000000.00
CVE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -3000000.00
CVE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -369000000.00
CVE balance_sheet (annual, 2023-12-31) — Net PPE: 39668000000.00
CVE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
CVE cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
CVE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 58000000.00
CVE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 25775000000.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 75000000.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 696000000.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4188000000.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 0.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 696000000.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 4188000000.00
CVE balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 276000000.00
CVE income_statement (annual, 2023-12-31) — Normalized EBITDA: 10565000000.00
CVE income_statement (annual, 2023-12-31) — Normalized Income: 4237770000.00
CVE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 7388000000.00
CVE cash_flow (annual, 2023-12-31) — Operating Gains Losses: -91000000.00
CVE income_statement (annual, 2023-12-31) — Operating Income: 5622000000.00
CVE income_statement (annual, 2023-12-31) — Operating Revenue: 55474000000.00
CVE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1871868729.00
CVE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 164000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1208000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Equity Interest: 25000000.00
CVE income_statement (annual, 2023-12-31) — Other Gand A: 342000000.00
CVE income_statement (annual, 2023-12-31) — Other Income Expense: -44000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Investments: 61000000.00
CVE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 32000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 287000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 554000000.00
CVE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 63000000.00
CVE income_statement (annual, 2023-12-31) — Other Operating Expenses: 6394000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Payable: 75000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Properties: 3942000000.00
CVE balance_sheet (annual, 2023-12-31) — Other Receivables: 22000000.00
CVE balance_sheet (annual, 2023-12-31) — Payables: 1238000000.00
CVE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5266000000.00
CVE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 284000000.00
CVE balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 36000000.00
CVE balance_sheet (annual, 2023-12-31) — Preferred Stock: 519000000.00
CVE cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -36000000.00
CVE income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 36000000.00
CVE balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 519000000.00
CVE cash_flow (annual, 2023-12-31) — Preferred Stock Payments: 0.00
CVE balance_sheet (annual, 2023-12-31) — Prepaid Assets: 242000000.00
CVE income_statement (annual, 2023-12-31) — Pretax Income: 5040000000.00
CVE cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: -647000000.00
CVE cash_flow (annual, 2023-12-31) — Purchase Of Business: -515000000.00
CVE cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
CVE balance_sheet (annual, 2023-12-31) — Raw Materials: 426000000.00
CVE balance_sheet (annual, 2023-12-31) — Receivables: 3209000000.00
CVE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 42770000000.00
CVE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 4644000000.00
CVE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1634000000.00
CVE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1061000000.00
CVE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 144000000.00
CVE balance_sheet (annual, 2023-12-31) — Retained Earnings: 8913000000.00
CVE income_statement (annual, 2023-12-31) — Salaries And Wages: 346000000.00
CVE cash_flow (annual, 2023-12-31) — Sale Of Business: 12000000.00
CVE income_statement (annual, 2023-12-31) — Selling General And Administration: 688000000.00
CVE balance_sheet (annual, 2023-12-31) — Share Issued: 1871868729.00
CVE income_statement (annual, 2023-12-31) — Special Income Charges: -164000000.00
CVE cash_flow (annual, 2023-12-31) — Stock Based Compensation: -12000000.00
CVE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 28698000000.00
CVE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 25256000000.00
CVE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -29230000.00
CVE income_statement (annual, 2023-12-31) — Tax Provision: 931000000.00
CVE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
CVE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 416000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Assets: 53915000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Capitalization: 35806000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Debt: 9945000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 28712000000.00
CVE income_statement (annual, 2023-12-31) — Total Expenses: 49852000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 25203000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 44207000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 18993000000.00
CVE income_statement (annual, 2023-12-31) — Total Other Finance Cost: 32000000.00
CVE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 88000000.00
CVE income_statement (annual, 2023-12-31) — Total Unusual Items: -158000000.00
CVE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -158000000.00
CVE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CVE balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
CVE balance_sheet (annual, 2023-12-31) — Working Capital: 3498000000.00
CVE income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: -31000000.00
CVE cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -329000000.00
CVE balance_sheet (quarterly, 2024-09-30) — Current Debt: 281000000.00
CVE balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 180000000.00
CVE balance_sheet (quarterly, 2024-09-30) — Preferred Shares Number: 36000000.00
CVE cash_flow (quarterly, 2024-09-30) — Preferred Stock Dividend Paid: -9000000.00
CVE income_statement (annual, 2024-12-31) — +Operating Expense: 7704000000.00
CVE income_statement (annual, 2024-12-31) — +Total Revenue: 57726000000.00
CVE balance_sheet (annual, 2024-12-31) — Accounts Payable: 5907000000.00
CVE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2378000000.00
CVE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -31439000000.00
CVE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 944000000.00
CVE income_statement (annual, 2024-12-31) — Basic Average Shares: 1850193000.00
CVE income_statement (annual, 2024-12-31) — Basic EPS: 1.68
CVE income_statement (quarterly, 2024-12-31) — Basic EPS: 0.08
CVE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2227000000.00
CVE cash_flow (annual, 2024-12-31) — Capital Expenditure: -5015000000.00
CVE cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -5015000000.00
CVE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2927000000.00
CVE balance_sheet (annual, 2024-12-31) — Capital Stock: 16015000000.00
CVE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3093000000.00
CVE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3093000000.00
CVE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1551000000.00
CVE balance_sheet (annual, 2024-12-31) — Cash Equivalents: 370000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 370000000.00
CVE balance_sheet (annual, 2024-12-31) — Cash Financial: 2723000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Cash Financial: 2723000000.00
CVE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -3505000000.00
CVE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -5126000000.00
CVE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 9235000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Account Payable: 299000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 322000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Inventory: -117000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 55000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Payable: 621000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 621000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Receivables: 746000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Tax Payable: 322000000.00
CVE cash_flow (annual, 2024-12-31) — Change In Working Capital: 1305000000.00
CVE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 547000000.00
CVE cash_flow (annual, 2024-12-31) — Changes In Cash: 604000000.00
CVE balance_sheet (annual, 2024-12-31) — Common Stock: 15659000000.00
CVE cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -1506000000.00
CVE cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -330000000.00
CVE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 29398000000.00
CVE cash_flow (annual, 2024-12-31) — Common Stock Payments: -1488000000.00
CVE income_statement (annual, 2024-12-31) — Cost Of Revenue: 44961000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 82000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 82000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Assets: 10434000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 359000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Debt: 365000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Current Debt: 365000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 724000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Liabilities: 7362000000.00
CVE balance_sheet (annual, 2024-12-31) — Current Provisions: 11000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Current Provisions: 11000000.00
CVE cash_flow (annual, 2024-12-31) — Deferred Income Tax: -474000000.00
CVE cash_flow (annual, 2024-12-31) — Deferred Tax: -474000000.00
CVE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 4871000000.00
CVE income_statement (annual, 2024-12-31) — Diluted Average Shares: 1863216000.00
CVE income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 1838961000.00
CVE income_statement (annual, 2024-12-31) — Diluted EPS: 1.67
CVE income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.07
CVE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 3106000000.00